Monopar Therapeutics Inc. (MNPR) Misses Q4 EPS by 1c

Monopar Therapeutics Inc. (NASDAQ: MNPR) reported Q4 EPS of ($0.22), $0.01 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Monopar Therapeutics Inc. (MNPR) click here.

You May Also Be Interested In

• Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
• Movano (MOVE) Misses Q2 EPS by 195c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M